The Motley FoolMon, 29 Jun 2026 23:52:02 GMTRelay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past YearRLAY+4.44%
Seeking AlphaMon, 08 Jun 2026 16:58:31 GMTRelay Therapeutics, Inc. (RLAY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptRLAY+4.44%
The Motley FoolFri, 22 May 2026 21:30:00 GMTIs Relay Therapeutics a Buy After Promising Trial Results?RLAY+4.44%
The Motley FoolWed, 20 May 2026 23:01:49 GMTWhy Relay Therapeutics Stock Popped on WednesdayRLAY+4.44%
Seeking AlphaWed, 20 May 2026 08:50:17 GMTRelay Therapeutics: Zovegalisib Is Becoming A Platform In DisguiseRLAY+4.44%
Seeking AlphaWed, 20 May 2026 03:10:53 GMTRelay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies TranscriptRLAY+4.44%
Investors Business DailyTue, 19 May 2026 10:00:31 GMTThis Biotech's Drug Just Wiped The Floor With ForecastsRLAY+4.44%
Zacks Investment ResearchTue, 05 May 2026 23:10:39 GMTRelay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesRLAY+4.44%
Seeking AlphaMon, 27 Apr 2026 20:21:31 GMTRelay Therapeutics, Inc. (RLAY) Discusses Zovegalisib Triplet Data and First-Line Breast Cancer Strategy TranscriptRLAY+4.44%
